Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yizhi Qingxin Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by Xiyuan Hospital of the China Academy of Chinese Medical Sciences. It is designed for the treatment of hypertension and mild cognitive impairment (MCI) in elderly patients, particularly those diagnosed with the TCM pattern of Deficiency of Kidney Essence Syndrome. The formula is available in both decoction and capsule forms and is administered orally. It aims to improve cognitive performance and manage blood pressure by addressing systemic deficiencies associated with aging and kidney essence depletion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yizhi Qingxin Decoction.